We’re using cookies to give you the best experience possible of Essity.com. Read more about the cookies we use and how to change your settings:
Essity had, previous to the acquisition of BSN medical, already significant sales to the healthcare sector through incontinence institutional operations. Essity develops, produces and sells incontinence products, baby diapers and feminine care products. Medical Solutions, a part of Essity following the acquisition of BSN medical on April 3, 2017, will be included in Personal Care as of Q2 2017 and comprises products within wound care, compression therapy and orthopedics.
Within these product segments, Essity also offers such products as wet wipes, soap, lotion, baby oil cotton pads. The products are sold under Essity’s global and regional brands, such as Cutimed, Delta, Jobst, Leukoplast, Libero, Libresse, Nosotras, Saba and TENA, as well as under retailers’ brands. Distribution channels for the products are the retail trade, online sales, hospitals, pharmacies, care institutions and sanitary shops.
In 2016, net sales in the Personal Care business area amounted to approximately SEK 34bn and accounted for 33% of Essity’s net sales in 2016. The globally leading brand for incontinence products, TENA, is the largest brand in Personal Care, a “billion-dollar brand” with annual net sales exceeding SEK 15bn. At the end of the year, Essity had production at 27 plants in 21 countries. BSN medical operates 15 manufacturing sites in eleven countries.